Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1996 Oct;49(10):858–860. doi: 10.1136/jcp.49.10.858

Granulocyte-colony stimulating factor concentrations in a patient with plasma cell dyscrasia and clinical features of chronic neutrophilic leukaemia.

M Nagai 1, S Oda 1, M Iwamoto 1, K Marumoto 1, M Fujita 1, J Takahara 1
PMCID: PMC500786  PMID: 8943758

Abstract

In order to study the pathogenesis of plasma cell dyscrasias with associated clinical features of chronic neutrophilic leukaemia, the concentration of granulocyte-colony stimulating factor (G-CSF) was measured in a patient, a 73 year old man, who underwent steroid pulse therapy. High G-CSF concentrations and leucocyte counts prior to treatment declined rapidly on administration of dexamethazone, but rose subsequently. G-CSF was not detected in primary cultures of bone marrow cells, but large amounts of interleukin-6 were found in the culture supernatant. These observations suggest that the neutrophilia observed in the patient represented a reactive response to G-CSF secreted from abnormal plasma cells or stromal cells rather than the existence of a genuine myeloproliferative disorder.

Full text

PDF
858

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T., Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990 Jun;9(6):1897–1906. doi: 10.1002/j.1460-2075.1990.tb08316.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bareford D., Jacobs P. Chronic neutrophilic leukaemia. Am J Clin Pathol. 1980 Jun;73(6):837–837. doi: 10.1093/ajcp/73.6.837. [DOI] [PubMed] [Google Scholar]
  3. Caligaris-Cappio F., Bergui L., Gregoretti M. G., Gaidano G., Gaboli M., Schena M., Zallone A. Z., Marchisio P. C. 'Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood. 1991 Jun 15;77(12):2688–2693. [PubMed] [Google Scholar]
  4. Klein B., Zhang X. G., Lu Z. Y., Bataille R. Interleukin-6 in human multiple myeloma. Blood. 1995 Feb 15;85(4):863–872. [PubMed] [Google Scholar]
  5. Lichtenstein A., Berenson J., Norman D., Chang M. P., Carlile A. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood. 1989 Sep;74(4):1266–1273. [PubMed] [Google Scholar]
  6. Naparstek Y., Zlotnick A., Polliack A. Coexistent chronic myeloid leukemia and IgA monoclonal gammopathy: report of a case and review of the literature. Am J Med Sci. 1980 Mar-Apr;279(2):111–115. doi: 10.1097/00000441-198003000-00005. [DOI] [PubMed] [Google Scholar]
  7. Portier M., Zhang X. G., Ursule E., Lees D., Jourdan M., Bataille R., Klein B. Cytokine gene expression in human multiple myeloma. Br J Haematol. 1993 Nov;85(3):514–520. doi: 10.1111/j.1365-2141.1993.tb03341.x. [DOI] [PubMed] [Google Scholar]
  8. Ray A., LaForge K. S., Sehgal P. B. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol. 1990 Nov;10(11):5736–5746. doi: 10.1128/mcb.10.11.5736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Standen G. R., Jasani B., Wagstaff M., Wardrop C. A. Chronic neutrophilic leukemia and multiple myeloma. An association with lambda light chain expression. Cancer. 1990 Jul 1;66(1):162–166. doi: 10.1002/1097-0142(19900701)66:1<162::aid-cncr2820660129>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  10. Standen G. R., Steers F. J., Jones L. Clonality of chronic neutrophilic leukaemia associated with myeloma: analysis using the X-linked probe M27 beta. J Clin Pathol. 1993 Apr;46(4):297–298. doi: 10.1136/jcp.46.4.297. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES